Cargando…
Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-κB inhibition in acute myeloid leukemia (AML)
Acute myeloid leukemia (AML) is a bone marrow derived blood cancer where intercellular communication in the leukemic bone marrow participates in disease development, progression and chemoresistance. Tunneling nanotubes (TNTs) are intercellular communication structures involved in transport of cellul...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352373/ https://www.ncbi.nlm.nih.gov/pubmed/27974700 http://dx.doi.org/10.18632/oncotarget.13853 |
_version_ | 1782514950741164032 |
---|---|
author | Omsland, Maria Bruserud, Øystein Gjertsen, Bjørn T Andresen, Vibeke |
author_facet | Omsland, Maria Bruserud, Øystein Gjertsen, Bjørn T Andresen, Vibeke |
author_sort | Omsland, Maria |
collection | PubMed |
description | Acute myeloid leukemia (AML) is a bone marrow derived blood cancer where intercellular communication in the leukemic bone marrow participates in disease development, progression and chemoresistance. Tunneling nanotubes (TNTs) are intercellular communication structures involved in transport of cellular contents and pathogens, also demonstrated to play a role in both cell death modulation and chemoresistance. Here we investigated the presence of TNTs by live fluorescent microscopy and identified TNT formation between primary AML cells and in AML cell lines. We found that NF-κB activity was involved in TNT regulation and formation. Cytarabine downregulated TNTs and inhibited NF-κB alone and in combination with daunorubicin, providing additional support for involvement of the NF-κB pathway in TNT formation. Interestingly, daunorubicin was found to localize to lysosomes in TNTs connecting AML cells indicating a novel function of TNTs as drug transporting devices. We conclude that TNT communication could reflect important biological features of AML that may be explored in future therapy development. |
format | Online Article Text |
id | pubmed-5352373 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-53523732017-04-14 Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-κB inhibition in acute myeloid leukemia (AML) Omsland, Maria Bruserud, Øystein Gjertsen, Bjørn T Andresen, Vibeke Oncotarget Research Paper Acute myeloid leukemia (AML) is a bone marrow derived blood cancer where intercellular communication in the leukemic bone marrow participates in disease development, progression and chemoresistance. Tunneling nanotubes (TNTs) are intercellular communication structures involved in transport of cellular contents and pathogens, also demonstrated to play a role in both cell death modulation and chemoresistance. Here we investigated the presence of TNTs by live fluorescent microscopy and identified TNT formation between primary AML cells and in AML cell lines. We found that NF-κB activity was involved in TNT regulation and formation. Cytarabine downregulated TNTs and inhibited NF-κB alone and in combination with daunorubicin, providing additional support for involvement of the NF-κB pathway in TNT formation. Interestingly, daunorubicin was found to localize to lysosomes in TNTs connecting AML cells indicating a novel function of TNTs as drug transporting devices. We conclude that TNT communication could reflect important biological features of AML that may be explored in future therapy development. Impact Journals LLC 2016-12-10 /pmc/articles/PMC5352373/ /pubmed/27974700 http://dx.doi.org/10.18632/oncotarget.13853 Text en Copyright: © 2017 Omsland et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Omsland, Maria Bruserud, Øystein Gjertsen, Bjørn T Andresen, Vibeke Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-κB inhibition in acute myeloid leukemia (AML) |
title | Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-κB inhibition in acute myeloid leukemia (AML) |
title_full | Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-κB inhibition in acute myeloid leukemia (AML) |
title_fullStr | Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-κB inhibition in acute myeloid leukemia (AML) |
title_full_unstemmed | Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-κB inhibition in acute myeloid leukemia (AML) |
title_short | Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-κB inhibition in acute myeloid leukemia (AML) |
title_sort | tunneling nanotube (tnt) formation is downregulated by cytarabine and nf-κb inhibition in acute myeloid leukemia (aml) |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352373/ https://www.ncbi.nlm.nih.gov/pubmed/27974700 http://dx.doi.org/10.18632/oncotarget.13853 |
work_keys_str_mv | AT omslandmaria tunnelingnanotubetntformationisdownregulatedbycytarabineandnfkbinhibitioninacutemyeloidleukemiaaml AT bruserudøystein tunnelingnanotubetntformationisdownregulatedbycytarabineandnfkbinhibitioninacutemyeloidleukemiaaml AT gjertsenbjørnt tunnelingnanotubetntformationisdownregulatedbycytarabineandnfkbinhibitioninacutemyeloidleukemiaaml AT andresenvibeke tunnelingnanotubetntformationisdownregulatedbycytarabineandnfkbinhibitioninacutemyeloidleukemiaaml |